Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.09 – $0.11
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.5M | $3.3M | $20.6M | $36.9M | $50.7M | $56.0M | $62.7M | $46.8M |
| Cost of revenue | $0 | $8.1M | $727.0K | $963.0K | $41.6M | $45.6M | $66.8M | $52.9M |
| Gross profit | $12.5M | −$4.8M | $19.9M | $35.9M | $9.1M | $13.0M | $62.7M | −$6.1M |
| Gross margin | 100.0% | -145.6% | 96.5% | 97.4% | 17.9% | 23.3% | 100.0% | -13.1% |
| R&D | $0 | $0 | $0 | $0 | $82.0K | $0 | $0 | −$5.8M |
| Operating income | −$2.1M | −$5.0M | −$10.3M | $590.0K | $6.0M | $10.1M | $12.9M | −$348.9K |
| EBITDA | −$3.7M | −$4.8M | −$8.6M | $3.1M | $7.1M | $14.0M | $17.8M | $4.3M |
| Net income | −$4.3M | −$5.7M | −$10.8M | −$74.0K | −$776.0K | $16.1M | $10.7M | −$6.0M |
| Net margin | -34.3% | -172.2% | -52.4% | -0.2% | -1.5% | 28.8% | 17.0% | -12.8% |
| EPS (diluted) | -0.06 | -0.03 | -0.02 | -0.00 | -0.00 | 0.02 | 0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $49M | $-0.01 | $-0.01–$-0.00 | 1 |
| 2027 | $54M | $-0.00 | $-0.00–$-0.00 | 1 |
| 2028 | $58M | $0.00 | $0.00–$0.00 | 1 |
| 2029 | $67M | $0.01 | $0.01–$0.01 | 1 |
Forward consensus · source: Financial Modeling Prep
OPEN ORPHAN PLC
No one on the platform currently holds OPORF.
No tracked institution reports a position in OPORF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-05-16 | $0.0020 | 2025-06-11 |
| 2024-04-18 | $0.0020 | 2024-05-20 |
No one on the platform has traded OPORF yet.
| $539M |
| — |
| HNSBFHansa Biopharma AB | $2.90 | +0.00% | $246M | — |
| ORPEFOrpea S.A. | $14.22 | +0.00% | $2.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.